Suppr超能文献

整联蛋白糖蛋白 CUB 结构域包含蛋白 1(CDCP1)的蛋白水解诱导的 N 端细胞外结构域脱落伴随着其 C 端结构域的酪氨酸磷酸化以及Src 和 PKCdelta 的募集。

Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.

机构信息

Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland 4059, Australia.

出版信息

J Biol Chem. 2010 Aug 20;285(34):26162-73. doi: 10.1074/jbc.M109.096453. Epub 2010 Jun 15.

Abstract

CUB-domain-containing protein 1 (CDCP1) is an integral membrane glycoprotein with potential as a marker and therapeutic target for a number of cancers. Here we examine mechanisms regulating cellular processing of CDCP1. By analyzing cell lines exclusively passaged non-enzymatically and through use of a panel of protease inhibitors, we demonstrate that full-length 135 kDa CDCP1 is post-translationally processed in a range of cell lines by a mechanism involving serine protease activity, generating a C-terminal 70-kDa fragment. Immunopurification and N-terminal sequencing of this cell-retained fragment and detailed mutagenesis, show that proteolytic processing of CDCP1 occurs at two sites, Arg-368 and Lys-369. We show that the serine protease matriptase is an efficient, but not essential, cellular processor of CDCP1 at Arg-368. Importantly, we also demonstrate that proteolysis induces tyrosine phosphorylation of 70-kDa CDCP1 and recruitment of Src and PKCdelta to this fragment. In addition, Western blot and mass spectroscopy analyses show that an N-terminal 65-kDa CDCP1 ectodomain is shed intact from the cell surface. These data provide new insights into mechanisms regulating CDCP1 and suggest that the biological role of this protein and, potentially, its function in cancer, may be mediated by both 70-kDa cell retained and 65-kDa shed fragments, as well as the full-length 135-kDa protein.

摘要

CUB 结构域蛋白 1(CDCP1)是一种完整的膜糖蛋白,具有作为多种癌症的标志物和治疗靶点的潜力。在这里,我们研究了调节细胞内 CDCP1 处理的机制。通过分析仅通过非酶途径传代的细胞系和使用蛋白酶抑制剂组合,我们证明在多种细胞系中,全长 135 kDa 的 CDCP1 通过涉及丝氨酸蛋白酶活性的机制进行翻译后加工,产生 C 端 70 kDa 片段。对该细胞保留片段进行免疫纯化和 N 端测序以及详细的诱变分析表明,CDCP1 的蛋白水解加工发生在两个位点,Arg-368 和 Lys-369。我们表明丝氨酸蛋白酶 matriptase 是 CDCP1 在 Arg-368 处的有效但不是必需的细胞处理器。重要的是,我们还证明蛋白水解诱导 70 kDa CDCP1 的酪氨酸磷酸化以及 Src 和 PKCdelta 募集到该片段。此外,Western blot 和质谱分析表明完整的 65 kDa CDCP1 细胞外结构域从细胞表面完整脱落。这些数据提供了有关调节 CDCP1 的机制的新见解,并表明该蛋白的生物学作用及其在癌症中的功能可能由 70 kDa 细胞保留片段和 65 kDa 脱落片段以及全长 135 kDa 蛋白介导。

相似文献

6
The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
Oncogene. 2012 Feb 2;31(5):653-63. doi: 10.1038/onc.2011.262. Epub 2011 Jul 4.
8
Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation.
PLoS One. 2012;7(12):e53050. doi: 10.1371/journal.pone.0053050. Epub 2012 Dec 31.

引用本文的文献

2
CUB domain-containing protein 1 signaling dysregulates gemcitabine metabolism contributing to therapeutic resistance in T24 cells.
PLoS One. 2025 Sep 2;20(9):e0331289. doi: 10.1371/journal.pone.0331289. eCollection 2025.
4
Theranostic Targeting of CUB Domain-Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer.
Clin Cancer Res. 2023 Apr 3;29(7):1232-1242. doi: 10.1158/1078-0432.CCR-22-1973.
5
The roles of proteases in prostate cancer.
IUBMB Life. 2023 Jun;75(6):493-513. doi: 10.1002/iub.2700. Epub 2023 Jan 4.
8
Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancer.
Oncogene. 2022 Jun;41(23):3251-3262. doi: 10.1038/s41388-022-02327-5. Epub 2022 May 5.
10
Repurposing Tranexamic Acid as an Anticancer Agent.
Front Pharmacol. 2022 Jan 13;12:792600. doi: 10.3389/fphar.2021.792600. eCollection 2021.

本文引用的文献

2
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.
Cancer Res. 2009 Nov 1;69(21):8395-402. doi: 10.1158/0008-5472.CAN-09-1995. Epub 2009 Oct 20.
3
4
Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination.
Mol Cancer Res. 2009 Aug;7(8):1197-211. doi: 10.1158/1541-7786.MCR-09-0100. Epub 2009 Aug 11.
6
The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation.
Am J Pathol. 2009 May;174(5):1756-65. doi: 10.2353/ajpath.2009.080890. Epub 2009 Apr 6.
7
Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.
Clin Cancer Res. 2009 Apr 1;15(7):2311-22. doi: 10.1158/1078-0432.CCR-08-2533. Epub 2009 Mar 24.
8
Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides.
FEBS J. 2009 Apr;276(8):2213-26. doi: 10.1111/j.1742-4658.2009.06950.x. Epub 2009 Mar 3.
9
Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease.
J Pharmacol Exp Ther. 2009 May;329(2):764-74. doi: 10.1124/jpet.108.148155. Epub 2009 Feb 3.
10
Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.
Cancer Sci. 2009 Mar;100(3):429-33. doi: 10.1111/j.1349-7006.2008.01066.x. Epub 2008 Dec 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验